Member Info for Livedataaccount

Good news

This is massive news and with it being in the US will not only speed up the trial but give Avacta gravitas within the Science and investment fraternity.
mtd could be found immenantly leading to mid year start of phase 1b. I personally don't expect the share price to go bonkers when/if the rns comes shortly into 1B that they have proven efficacy in soft tissue sarcoma. Running up to this point speculation will be rife

Avacta

LONDON | NEW YORK | WETHERBY

Non-deal roadshows (NDRs) offer investors a comprehensive look at a company's story that press releases, conference presentations, and other public documents cannot. Public and private companies alike may benefit from scheduling NDRs to foster effective communication between the executive team and investors

Avacta are now doing a non-deal road show for institutional investors , hosted by Stifel, today and tomorrow. Hopefully that will be a busy one.

Retail investment appears to be exhausted.
A real shame this British company isn't currently getting the backing it deserves

Can only hope there were some serious investors watching the presentation.
Avacta is crying out for institutional Investment. And seems that is what's needed to move the shareprice.

Good news

That's the. One, Hurstbot!

Good news!

Any news of significance will have to released in a separate RNS.
Please all temper your expectations.

Unlikely the Mexicans will be online for the presentation tomorrow at 11. So, can't see big news being announced.

They are different technologies

That along with orphan drug Designation with the FDA for soft tissue sarcoma.

Not good for existing shareholders if Avacta grows to a ~ 2 billion pound company but has to quadruple the shares in issue just to remain independent

Be good to hear how the CEO plans to finance all these projects and minimise share dilution.

Americans arriving

This is huge news!.

Hopefully get the maximum dose tolerance shortly

Maybe Avacta need to turn to China?